Observational studyRevista da Associacao Medica Brasileira (1992)2026
Gender-based comparison of clinical, epidemiological, and laboratory characteristics in hemodialysis patients: a retrospective analysis.
Observational study in Revista da Associacao Medica Brasileira (1992), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Comment on: "Gender-based comparison of clinical, epidemiological, and laboratory characteristics in hemodialysis patients: a retrospective analysis".Revista da Associacao Medica Brasileira (1992) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveThe aim of this study was to analyze and compare the clinical, epidemiological, and laboratory characteristics of male and female patients with kidney disease admitted for hemodialysis.
methodsThis retrospective, observational, cross-sectional study analyzed the clinical, epidemiological, and laboratory data from electronic health records of patients admitted for hemodialysis at a university hospital between January 2022 and November 2023, comparing men's and women's profiles. All adult patients were consecutively included, except those with missing data.
resultsA total of 163 patients were included: 53.9% of whom were male and 43.4% self-identified as white. Chronic kidney disease was diagnosed at admission in 78.5% of cases, with diabetes mellitus being the leading etiology, affecting 20.4% of men and 26.6% of women. Men had significantly higher serum creatinine (7.9 vs. 6.3 mg/dL; p<0.001), potassium (4.8 vs. 4.6 mEq/L, p=0.039), and phosphorus levels (5.9 vs. 5.0 mg/dL; p=0.004), whereas women had significantly higher high-density lipoprotein cholesterol cholesterol (46 vs. 37 mg/dL; p<0.001), low-density lipoprotein cholesterol cholesterol (120.4 vs. 97.8 mg/dL; p=0.004), and total cholesterol (198 vs. 161 mg/dL; p<0.001). Among patients with diabetes mellitus, women more frequently used statins (67.7 vs. 42.4%; p=0.042) and angiotensin II type 1 receptor blockers (58.1 vs. 27.3%; p=0.013). They also had higher total cholesterol (199 vs. 156 mg/dL; p=0.005) and low-density lipoprotein cholesterol cholesterol levels (117 vs. 92 mg/dL; p=0.043), while men had higher serum phosphorous levels (6.3 vs. 5.0 mg/dL; p=0.028).
conclusionSignificant gender-based differences were identified in the clinical, epidemiological, and laboratory characteristics of patients admitted for hemodialysis. Men presented higher serum creatinine, phosphorus, and potassium levels, whereas women showed higher cholesterol fractions and greater use of statins and angiotensin II type 1 receptor blockers.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.